Fear of hypoglycaemia in patients with type 1 diabetes
Independently of causes and risk factors of hypoglycaemia, its manifestations are always unfavourable and evoke fear and other negative emotions that lead to negative consequences connected with quality of diabetes control. The fear of hypoglycaemia creates an internal conflict by diminishing patien...
Guardado en:
Autores principales: | Evgenia Mikhailovna Patrakeeva, Mariia Nikolayevna Dunicheva, Alsu Gafurovna Zalevskaya |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e96ef25d48c14c099c2b55c3769e2928 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insulin degludec is a new ultra-long-acting insulin analogue
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014) -
National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
por: Gagik Radikovich Galstyan
Publicado: (2014) -
Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014) -
Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice
por: Lyudmila Alexandrovna Suplotova, et al.
Publicado: (2015) -
The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
por: Vadim V. Klimontov, et al.
Publicado: (2015)